[1]
“Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients”, Mediterr J Hematol Infect Dis, vol. 2, no. 1, p. e2010035, Dec. 2010, doi: 10.4084/mjhid.2010.035.